August 2026

1553 articles
Auravelle Metals reports strong preliminary metallurgical results from its Sheoak Prospect, confirming high gold recoveries and non-refractory mineralisation amenable to conventional processing.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Cosmo Metals has initiated a systematic soil sampling campaign at its Plunkett & Cassidy antimony prospect within the extensive Antimony Gully Trend at Bingara, NSW, following rock chip assays up to 10.3% antimony. The program aims to delineate mineralised strike extensions and prioritise drill targets in a region hosting Larvotto Resources’ Hillgrove deposit.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Centrepoint Alliance has acquired a 51% controlling interest in SEQ Advice Group, targeting an initial $0.6 million EBITDA boost and a path to $1.9 million by FY31 through increased ownership.
Claire Turing
Claire Turing
25 Aug 2026
HiTech Group has secured unconditional ACCC clearance for its acquisition of Hudson Global Resources’ Australian assets, removing a major regulatory obstacle ahead of completion.
Victor Sage
Victor Sage
25 Aug 2026
Talonx Resources is gearing up for a fresh RC drilling campaign at its Beaker 2 Prospect within the Viking Gold Project to underpin a maiden Mineral Resource estimate. The program aims to extend high-grade gold zones and densify drilling in the shallow oxide gold area, which remains open-ended.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Duketon Mining has kicked off a 2,500-metre reverse circulation drilling program at its Barlee Gold Project, aiming to extend promising gold mineralisation identified in its maiden campaign and supported by strong soil geochemistry.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Atturra Limited’s FY26 results reveal a sharp net loss driven by a $22.8 million goodwill impairment, overshadowing a 17% revenue increase to $351.8 million. The company is banking on AI and strategic acquisitions to fuel a turnaround in FY27.
Victor Sage
Victor Sage
25 Aug 2026
Sandfire Resources Ltd (ASX:SFR) posted a 41% revenue jump to $1.65 billion and a 282% surge in net profit to $355.8 million for FY26, driven by strong operational performance and robust commodity prices. The company declared a fully franked 35 Australian cents per share dividend and advanced its Kalkaroo Copper-Gold Project with a $70 million pre-feasibility study underway.
Maxwell Dee
Maxwell Dee
25 Aug 2026
PolyNovo reported a 16.1% rise in FY26 revenue to AUD 150 million, driven by strong global sales and manufacturing expansion, yet net profit fell 44% due to a significant asset write-off from an R&D centre fire and lower tax benefits.
Ada Torres
Ada Torres
25 Aug 2026
Monvia Limited reported a $28.7 million revenue year with a $6.9 million adjusted EBITDA, exceeding IPO forecasts, while renewing a $60 million contract with MetLife and completing its ASX listing.
Sophie Babbage
Sophie Babbage
25 Aug 2026
London City Equities delivered a remarkable 1460% jump in profit after tax for FY2026, driven by key asset sales and liquidation gains, while maintaining a cautious investment stance and confirming a steady dividend payout.
Claire Turing
Claire Turing
25 Aug 2026
Vysarn Limited reported a robust 31.5% increase in revenue to $140 million for FY2026, driven by strong performances across its industrial, advisory, and technology segments. The company is accelerating its national footprint with strategic acquisitions and progressing the Kariyarra Water Scheme.
Victor Sage
Victor Sage
25 Aug 2026
Wisr Limited has reported its inaugural full-year Cash NPAT profit of $1.0 million for FY26, driven by a 65% surge in loan originations and a 32% expansion in its loan book, surpassing $1 billion for the first time.
Claire Turing
Claire Turing
25 Aug 2026
Veris Limited lifted revenue by 4.9% to $102 million in FY26, driven by digital and advisory growth, but statutory net profit fell 67% amid one-off costs and macroeconomic headwinds.
Victor Sage
Victor Sage
25 Aug 2026
Flight Centre Travel Group posted record total transaction value (TTV) of $25.7 billion in FY26, with statutory profit after tax surging 38% despite a $60 million Q4 leisure profit hit from Middle East tensions. The company declared a fully franked 30c dividend and launched a new $200 million buy-back program.
Victor Sage
Victor Sage
25 Aug 2026
Complii FinTech Solutions expanded into institutional markets with a major contract, raised $2 million via convertible notes, and facilitated $22.48 billion capital raising on its platform in FY26.
Claire Turing
Claire Turing
25 Aug 2026
Winton Land reported a 120% rise in net profit to $22.7 million in FY26, driven by increased residential settlements and full-year trading at its hospitality venues, despite economic headwinds and leadership changes.
Eva Park
Eva Park
25 Aug 2026
Scott Technology aims to more than double Protein Domain revenue to NZ$165 million by FY30, leveraging global growth of its BladeStop safety bandsaw and a new Mexico distribution deal.
Victor Sage
Victor Sage
25 Aug 2026
Meridian Energy (NZX:MEL) reported a strong turnaround in FY26 with a $130 million net profit after tax, driven by improved hydro and wind generation, retail growth, and strategic investments in renewable projects and grid flexibility.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Scales Corporation delivered a record first half in 2026 with revenues soaring 105% to NZ$762.1 million and underlying EBITDA up 18% to NZ$102.2 million. The diversified agribusiness raised its full year profit guidance despite challenges in Europe and the Middle East.
Victor Sage
Victor Sage
25 Aug 2026
Steel & Tube Holdings reported a 13.9% revenue rise and a 376% jump in normalised EBITDA for FY26, despite a statutory net loss of NZD 61.2 million driven by significant asset impairments and ongoing market challenges.
Victor Sage
Victor Sage
25 Aug 2026
NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.
Ada Torres
Ada Torres
25 Aug 2026
Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.
Ada Torres
Ada Torres
25 Aug 2026
Steadfast Group delivered double-digit underlying EBITA growth in FY26 alongside a recommended $6 per share acquisition offer, reflecting a premium of nearly 52%. The insurer broker network continues to expand, supported by technology upgrades and international acquisitions.
Claire Turing
Claire Turing
25 Aug 2026